Lowering Thrombin Levels Offers a Double Benefit in Glomerular Disease Model
Lowering Thrombin Levels Offers a Double Benefit in Glomerular Disease Model https://pediatricsnationwide.org/wp-content/uploads/2026/03/Gloms-1-header-for-web-1024x410.jpg 1024 410 Katie Brind'Amour, PhD, MS, CHES https://pediatricsnationwide.org/wp-content/uploads/2021/03/Katie-B-portrait.gifPreclinical studies suggest that reducing levels of the clotting enzyme may simultaneously reduce kidney damage and lower risk of blood clots. Preclinical research in an in vivo model now confirms what Bryce Kerlin, MD, and his team first proposed in a publication 8 years ago: excess thrombin directly injures podocytes, and high levels in the…



































